IPC
EBS icon

Independent Portfolio Consultants’s Emergent Biosolutions EBS Stock Holding History

Independent Portfolio Consultants’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,330
Closed -$31.7K – 807
2014
Q3 		$28K Sell
1,330
-6,070
-82% -$139K 0.01% 681
2014
Q2 		$166K Buy
+7,400
New +$172K 0.05% 468

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Independent Portfolio Consultants's EBS Position: Q4 2014 in Review

Independent Portfolio Consultants sold out of Emergent Biosolutions (EBS) in Q4 2014, closing a stake of 1,330 shares — an estimated $31.7K sold.

Independent Portfolio Consultants first reported a position in EBS in Q2 2014 and held it in 2 quarters. The position peaked at $166K in Q2 2014. 167 funds tracked by Wall St. Rank hold EBS as of Q4 2014.

  • Independent Portfolio Consultants reported no remaining Emergent Biosolutions position as of Q4 2014 after selling out during the quarter.
  • Independent Portfolio Consultants sold 1,330 Emergent Biosolutions shares in Q4 2014, an estimated $31.7K.
  • Independent Portfolio Consultants first reported a position in Emergent Biosolutions in Q2 2014 and held it in 2 quarters.
  • Independent Portfolio Consultants's Emergent Biosolutions position peaked at $166K in Q2 2014.
  • 167 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2014.

Based on Independent Portfolio Consultants's 13F filing for Q4 2014, filed 17 Feb 2015.